In this Section |
3346.0 Health Economics: Economic Evaluation of InterventionsMonday, November 9, 2009: 2:30 PM
Oral
This session presents abstracts on costs and cost-effectiveness of five programs. The abstracts report on the cost-effectiveness of disease modifying therapies (DMTs) to treat MS compared to no DMT, the cost-effectiveness of a tele-ICU program, the cost-effectiveness of expanding access to comprehensive care for chronic hepatitis B infection, the cost-effectiveness of a navigation program for breast cancer patients, and the costs associated with medical utilization and productivity in overweight and obese workers.
Session Objectives: 1. Evaluate the cost-effectiveness of disease modifying therapies (DMTs) to treat multiple sclerosis compared to no DMT.
2. Evaluate the economic outcomes associated with the implementation of a Tele-ICU program across 6 ICUs.
3. Analyze the costs, benefits, and cost-effectiveness of expanded access to care for patients with hepatitis B using a Markov state transition model
4. Evaluate the cost-effectiveness of a public health program that addresses disparities in breast cancer prognosis.
5.Identify the differences in healthcare utilization and productivity outcomes for obese and overweight employees compared to normal weight employees.
Moderator:
Luisa Franzini, PhD
2:30 PM
3:00 PM
3:15 PM
3:30 PM
See individual abstracts for presenting author's disclosure statement and author's information. Organized by: Medical Care
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)
See more of: Medical Care
|